《中国围手术期感染预防与管理指南》解读

Interpretation of Evidence-based Guideline for the Prevention and Management of Perioperative Infection

《中国围手术期感染预防与管理指南》是首都医科大学附属北京天坛医院药学部牵头,联合51个医疗机构、科研院所共同制订。该指南聚焦于围手术期预防感染常见的临床问题,如住院时长、血糖控制、贫血与低蛋白血症、手术部位以外感染控制、处方前置审核、抗菌药物选择、给药时机、追加时机、延长用药、引流管拔除时机、患者宣教、消毒剂选择、环境清洁、人员流动、医务人员手卫生、健康状态及佩戴双层手套等,基于当前可获得的循证医学证据,最终形成强推荐意见16条,弱推荐意见18条,暂无法判断强度等级的意见2条。指南于2023年2月发表于Journal of Evidence-Based Medicine,本文为该指南的解读版本。

Evidence-based Guideline for the Prevention and Management of Perioperative Infection was launched by the Department of Pharmacy,Beijing Tiantan Hospital,Capital Medical University,associated with 51 medical institutions and research institutes.The guideline focused on common clinical questions of perioperative infection prevention,such as length of hospital stay,blood glucose control,anemia and hypoproteinemia,infection control outside the surgical site,prescription review,selection of antimicrobial,administration timing,additional timing,extension of antimicrobial,and timing of drainage tube removal,patient education,selection of disinfectants,environmental cleanliness,personnel flow,hand hygiene of medical staff,health status,and wearing double layer gloves.Based on the currently available evidence-based medical evidence,this guideline finally formed 16 strong recommendations,18 weak recommendations,and 2 opinions that cannot determine the intensity level.The guideline was published in the Journal of Evidence-Based Medicine in February 2023.This article is the interpretation version of the guideline.